The government agreed to buy more doses of an antibody drug for the early treatment of Covid-19 developed by GlaxoSmithKline and Vir Biotechnology, bringing its total order to nearly $1 billion.
U.S. Boosts Order for Glaxo's Covid-19 Antibody Drug
- Thread starterWSJ.com: US Business
- Start date
- Tags
- covid-19